// App-Quantinova.ai

3409 : Allogeneic Stem Cell Transplantation In Adults With High Risk Acute Lymphoblastic Leukemia (ALL) In 1. Remission (CR1): Promising, But Strongly Influenced By ALL Subtypes

Researchers

Presenter

  • Renate Arnold

Principal Investigators

  • Theis H. Terwey

  • Giang Lam Vuong

  • Benjamin Ostendorf

  • Olaf Penack

  • Gero Massenkeil

  • Nicola Gokbuget

  • Philipp G. Hemmati

Medical Centers

  • Dept of Pediatrics, University Hospital Frankfurt, Frankfurt, Germany

  • Hematology, Oncology, Gastroenterology, Klinikum Gutersloh, Gutersloh, Germany

  • Medizinische Klinik m.S., Hamatologie, Onkologie und Tumorimmunologie, Charite, Universitatsmedizin Berlin, Berlin, Germany

Locations

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Acute lymphoblastic leukemia

  • Philadelphia chromosome–positive (Ph+) ALL

  • B-cell acute lymphoblastic leukemia

  • T-cell acute lymphoblastic leukemia

  • Graft-versus-host disease

Biomarkers

  • Ph chromosome

  • Soluble Complement 5b-9

Drug/Treatment

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • fludarabine tablet

  • Busulfan

  • Etoposide phosphate

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved